Increase in Body Mass Index in Children With HIV, Switched to Tenofovir Alafenamide Fumarate or Dolutegravir Containing Antiretroviral Regimens

Pediatr Infect Dis J. 2021 May 1;40(5):e215-e216. doi: 10.1097/INF.0000000000003076.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Alanine / therapeutic use*
  • Anti-Retroviral Agents / therapeutic use*
  • Body Mass Index
  • Child
  • Cohort Studies
  • Dolutegravir
  • Female
  • HIV Infections / drug therapy*
  • Heterocyclic Compounds, 3-Ring / therapeutic use*
  • Humans
  • Male
  • Oxazines / therapeutic use*
  • Piperazines / therapeutic use*
  • Pyridones / therapeutic use*
  • Retrospective Studies
  • Tenofovir / analogs & derivatives*
  • Tenofovir / therapeutic use
  • Weight Gain / drug effects*

Substances

  • Alanine
  • Anti-Retroviral Agents
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • Tenofovir
  • Dolutegravir
  • tenofovir alafenamide